Table 3. Checkpoint inhibitors made by domestic companies that applied for new drug clinical trial application in China (until April 25, 2018).

Abbreviations: IgG, immunoglobulin G; IND, investigational new drug; mAb, monoclonal antibody; PD‐1, programmed cell death protein 1; PD‐L1, programmed death‐ligand 1.